$17.62
N/A
al cierre: -
$17.60
-0.02-0.11%
After hour: Nov 14, 7:27 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
KeyCorp tiene un precio objetivo de consenso de $19.54 basado en las calificaciones de 25 analistas. El máximo es $24, emitido por Morgan Stanley el septiembre 29, 2025. El mínimo es $16, emitido por Argus Research el abril 19, 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por DA Davidson, Truist Securities y UBS el octubre 17, 2025, octubre 17, 2025 y octubre 7, 2025, respectivamente. Con un precio objetivo promedio de $21 entre DA Davidson, Truist Securities y UBS, hay una 19.32% upside implícita para KeyCorp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
DA Davidson
Truist Securities
UBS
RBC Capital
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para KeyCorp
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/17/2025 | 19.32% | DA Davidson | $22 → $21 | Maintains | Buy | |||
10/17/2025 | 7.95% | Truist Securities | $20 → $19 | Maintains | Hold | |||
10/07/2025 | 30.68% | UBS | $22 → $23 | Maintains | Buy | |||
10/06/2025 | 13.64% | RBC Capital | $20 → $20 | Reiterates | Outperform → Outperform | |||
10/03/2025 | 25% | Wells Fargo | $20 → $22 | Maintains | Overweight | |||
09/30/2025 | 25% | Evercore ISI Group | $21 → $22 | Maintains | Outperform | |||
09/29/2025 | 36.36% | Morgan Stanley | $20 → $24 | Maintains | Equal-Weight | |||
07/28/2025 | 7.95% | Truist Securities | $17 → $19 | Maintains | Hold | |||
07/24/2025 | 13.64% | Citigroup | $19 → $20 | Downgrade | Buy → Neutral | |||
07/23/2025 | 19.32% | DA Davidson | $19 → $21 | Maintains | Buy | |||
07/08/2025 | 13.64% | Wells Fargo | $18 → $20 | Maintains | Overweight | |||
07/08/2025 | 25% | UBS | $16 → $22 | Upgrade | Neutral → Buy | |||
06/16/2025 | 13.64% | B of A Securities | $18 → $20 | Maintains | Buy | |||
05/21/2025 | 2.27% | Jefferies | → $18 | Initiates | → Hold | |||
04/22/2025 | -9.09% | Truist Securities | $18 → $16 | Maintains | Hold | |||
04/21/2025 | 2.27% | Keefe, Bruyette & Woods | $20 → $18 | Maintains | Outperform | |||
04/21/2025 | 13.64% | Barclays | $21 → $20 | Maintains | Equal-Weight | |||
04/07/2025 | 2.27% | Baird | $18 → $18 | Upgrade | Neutral → Outperform | |||
04/03/2025 | -6.25% | JP Morgan | $18.5 → $16.5 | Maintains | Neutral | |||
03/28/2025 | 13.64% | Wells Fargo | $22 → $20 | Maintains | Overweight | |||
03/24/2025 | 7.95% | Citigroup | $20 → $19 | Maintains | Buy | |||
03/21/2025 | 2.27% | Truist Securities | $19 → $18 | Maintains | Hold | |||
03/13/2025 | 13.64% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight | |||
03/10/2025 | 13.64% | Citigroup | → $20 | Upgrade | Neutral → Buy | |||
02/03/2025 | 5.11% | JP Morgan | → $18.5 | Assumes | → Neutral | |||
01/22/2025 | 2.27% | RBC Capital | $18 → $18 | Reiterates | Outperform → Outperform | |||
01/22/2025 | 13.64% | Stephens & Co. | $20 → $20 | Reiterates | Overweight → Overweight | |||
01/22/2025 | 19.32% | DA Davidson | $22 → $21 | Maintains | Buy | |||
01/22/2025 | 19.32% | Keefe, Bruyette & Woods | $22 → $21 | Maintains | Outperform | |||
01/22/2025 | 25% | Morgan Stanley | $23 → $22 | Maintains | Equal-Weight | |||
01/07/2025 | 7.95% | Truist Securities | → $19 | Initiates | → Hold | |||
01/06/2025 | 19.32% | Barclays | $19 → $21 | Maintains | Equal-Weight | |||
12/04/2024 | 25% | Keefe, Bruyette & Woods | $19 → $22 | Maintains | Outperform | |||
12/03/2024 | 25% | Piper Sandler | $19 → $22 | Maintains | Overweight | |||
11/26/2024 | 30.68% | Goldman Sachs | $20 → $23 | Maintains | Buy | |||
11/15/2024 | 25% | Wells Fargo | $20 → $22 | Maintains | Overweight | |||
11/07/2024 | 7.95% | Citigroup | → $19 | Downgrade | Buy → Neutral | |||
10/23/2024 | 2.27% | UBS | $17 → $18 | Maintains | Neutral | |||
10/21/2024 | 13.64% | DA Davidson | $19 → $20 | Maintains | Buy | |||
10/18/2024 | 7.95% | Barclays | $16 → $19 | Maintains | Equal-Weight | |||
10/18/2024 | 2.27% | RBC Capital | $17 → $18 | Maintains | Outperform | |||
10/14/2024 | -3.41% | Baird | $18 → $17 | Downgrade | Outperform → Neutral | |||
10/02/2024 | 13.64% | Evercore ISI Group | $18.5 → $20 | Maintains | Outperform | |||
09/24/2024 | 2.27% | Wedbush | $17 → $18 | Maintains | Neutral | |||
09/10/2024 | 2.27% | Keefe, Bruyette & Woods | $18 → $18 | Maintains | Outperform | |||
08/19/2024 | 7.95% | Jefferies | $18 → $19 | Maintains | Buy | |||
08/14/2024 | 13.64% | Morgan Stanley | $18 → $20 | Maintains | Equal-Weight | |||
08/13/2024 | -3.41% | RBC Capital | $17 → $17 | Reiterates | Outperform → Outperform | |||
08/13/2024 | 7.95% | Citigroup | $18 → $19 | Maintains | Buy | |||
08/13/2024 | -3.41% | Wedbush | $16 → $17 | Maintains | Neutral | |||
08/05/2024 | 2.27% | Morgan Stanley | $16 → $18 | Maintains | Equal-Weight | |||
07/19/2024 | -3.41% | RBC Capital | $16 → $17 | Maintains | Outperform | |||
07/19/2024 | 2.27% | DA Davidson | $16 → $18 | Maintains | Buy | |||
07/19/2024 | -9.09% | Wedbush | $15 → $16 | Maintains | Neutral | |||
07/08/2024 | -14.77% | UBS | $16 → $15 | Downgrade | Buy → Neutral | |||
06/27/2024 | -6.25% | JP Morgan | $17.5 → $16.5 | Maintains | Neutral | |||
06/25/2024 | -6.25% | Evercore ISI Group | — | $17.5 → $16.5 | Maintains | Outperform | ||
06/25/2024 | 132.95% | RBC Capital | $41 → $41 | Reiterates | Outperform → Outperform | |||
06/14/2024 | -0.57% | JP Morgan | $18 → $17.5 | Maintains | Neutral | |||
04/19/2024 | -9.09% | RBC Capital | $15 → $16 | Maintains | Outperform | |||
04/19/2024 | -9.09% | Argus Research | $15 → $16 | Maintains | Buy | |||
04/08/2024 | 2.27% | Jefferies | $17 → $18 | Maintains | Buy | |||
04/05/2024 | 2.27% | Keefe, Bruyette & Woods | $16 → $18 | Maintains | Outperform | |||
04/04/2024 | 2.27% | JP Morgan | $16 → $18 | Maintains | Neutral | |||
03/28/2024 | 2.27% | Wells Fargo | $16 → $18 | Maintains | Overweight | |||
03/28/2024 | 2.27% | Evercore ISI Group | — | $17 → $18 | Maintains | Outperform | ||
02/07/2024 | -9.09% | Morgan Stanley | $12 → $16 | Maintains | Equal-Weight | |||
01/26/2024 | -3.41% | Piper Sandler | $16 → $17 | Maintains | Overweight | |||
01/19/2024 | -9.09% | DA Davidson | $17 → $16 | Maintains | Buy | |||
01/19/2024 | — | Keefe, Bruyette & Woods | — | Maintains | Outperform | |||
01/19/2024 | -14.77% | RBC Capital | $13 → $15 | Maintains | Outperform | |||
01/19/2024 | -20.45% | Wedbush | $16 → $14 | Maintains | Neutral | |||
01/19/2024 | -9.09% | Barclays | $17 → $16 | Maintains | Equal-Weight | |||
01/09/2024 | -3.41% | Jefferies | $10 → $17 | Upgrade | Hold → Buy | |||
01/08/2024 | — | Raymond James | — | Initiates | → Market Perform | |||
01/03/2024 | -3.41% | Keefe, Bruyette & Woods | $15 → $17 | Maintains | Outperform | |||
01/02/2024 | -3.41% | Barclays | $13 → $17 | Maintains | Equal-Weight | |||
12/20/2023 | — | Stephens & Co. | — | Upgrade | Equal-Weight → Overweight | |||
12/18/2023 | -14.77% | Goldman Sachs | $13.5 → $15 | Maintains | Buy | |||
12/14/2023 | -9.09% | Wells Fargo | $12 → $16 | Maintains | Overweight | |||
12/05/2023 | -26.14% | Stephens & Co. | $13 → $13 | Reiterates | Equal-Weight → Equal-Weight | |||
12/05/2023 | -26.14% | RBC Capital | $14 → $13 | Maintains | Outperform | |||
12/04/2023 | -31.82% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight | |||
11/06/2023 | -14.77% | Keefe, Bruyette & Woods | → $15 | Upgrade | Market Perform → Outperform | |||
10/05/2023 | -31.82% | JP Morgan | $13 → $12 | Maintains | Neutral | |||
10/04/2023 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
09/27/2023 | -37.5% | Morgan Stanley | $10 → $11 | Maintains | Equal-Weight | |||
09/15/2023 | -23.3% | Piper Sandler | $12 → $13.5 | Upgrade | Neutral → Overweight | |||
08/02/2023 | — | JP Morgan | — | Upgrade | Underweight → Neutral | |||
07/24/2023 | -20.45% | Argus Research | $17 → $14 | Maintains | Buy | |||
07/24/2023 | -14.77% | Citigroup | $14 → $15 | Maintains | Buy | |||
07/24/2023 | -26.14% | Goldman Sachs | $11.5 → $13 | Maintains | Buy | |||
07/21/2023 | -43.18% | Morgan Stanley | $10 → $10 | Reiterates | Equal-Weight → Equal-Weight | |||
07/21/2023 | -26.14% | Wedbush | $10 → $13 | Maintains | Neutral | |||
07/21/2023 | -26.14% | Goldman Sachs | $11.5 → $13 | Maintains | Buy | |||
07/12/2023 | -20.45% | Citigroup | $15 → $14 | Maintains | Buy | |||
07/07/2023 | -43.18% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight | |||
06/29/2023 | -40.34% | JP Morgan | $11 → $10.5 | Maintains | Underweight | |||
06/13/2023 | -20.45% | RBC Capital | $16 → $14 | Maintains | Outperform | |||
06/13/2023 | -37.5% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de KeyCorp (KEY)?
El último precio objetivo de KeyCorp (NYSE:KEY) fue comunicado por DA Davidson el octubre 17, 2025. La firma de analistas fijó un precio objetivo para $21.00 que espera KEY a rise dentro de 12 meses (un posible 19.32% upside). 35 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre KeyCorp (KEY)?
La última calificación de analistas para KeyCorp (NYSE:KEY) fue proporcionada por DA Davidson, y KeyCorp mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de KeyCorp (KEY)?
La última revisión al alza de KeyCorp se produjo en julio 8, 2025, cuando UBS elevó su precio objetivo a $22. UBS anteriormente tenía a neutral para KeyCorp.
¿Cuándo fue la última revisión a la baja de KeyCorp (KEY)?
La última revisión a la baja de KeyCorp se produjo en julio 24, 2025, cuando Citigroup cambió su precio objetivo de $19 a $20 para KeyCorp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para KeyCorp (KEY)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de KeyCorp, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de KeyCorp se registró el octubre 17, 2025, por lo que la próxima calificación estará disponible en torno al octubre 17, 2026.
¿Es correcta la calificación de los analistas sobre KeyCorp (KEY)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de KeyCorp (KEY) fue un mantuvo con un precio objetivo de $22.00 a $21.00. El precio actual al que cotiza KeyCorp (KEY) es de $17.60, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.